Cancer Emerges as Pfizer's New Frontier, Says CEO Albert Bourla
Pfizer, the American pharmaceutical giant, is pivoting its focus to the lucrative field of cancer treatment following the decline in demand for its Covid-19 vaccines and therapies. CEO Albert Bourla revealed this strategic shift in an interview with Fox Business on May 1.